October 19–20, 2021
Europe’s largest meeting for life science industry professionals returns this October as hybrid event with free participation for both physical and digital edition. ELRIG’s flagship conference, Drug Discovery, brings together exhibiting companies and delegates to share the latest ground-breaking research in disease biology and to introduce cutting-edge advances in the application of laboratory technology.
We are delighted to be back in Liverpool (UK) and look forward to interesting conversations with you at our booth no. D6/D7. Don’t miss our talk on Ficoll-free primary cell isolation for drug discovery assays when you are around.
In case you shouldn’t be able to attend the event in person, we have put together some useful resources to enhance your drug discovery workflows here on this page. Check it out!
Whether you are performing killing assays for MoA studies, investigating immunogenicity, or analyzing early and late stage biomarkers, primary cells are essential for the discovery and development of new therapeutics. Conclusive and relevant assay results depend on reliable sample preparation, including Ficoll-free cell separation and efficient tumor dissociation. We have developed cell isolation solutions from various starting materials to ensure the best fit for every drug discovery program – join us to learn about the best methods and processes for your in vitro assays.
Marketing Manager, Miltenyi Biotec
Lotta Räty is Marketing Manager in the Strategic Marketing Department at Miltenyi Biotec, focusing on providing cell isolation solutions that simplify and speed up scientific discovery and development. Prior to her role in marketing and cell biology, Lotta worked in the genomics field as sales specialist for NGS and microarray CRO services as well as nucleic acid isolation instrumentation and reagents. She holds an MSc degree in Bioscience Technology from the University of York.
Seems like you are coming from USA!
Do you want to visit our website in your country?